Zaid Admani
👤 SpeakerAppearances Over Time
Podcast Appearances
So that could get really messy.
Don't be surprised if this decision leads to more market volatility.
So yeah, it's a very interesting moment in the markets right now.
We'll see how things play out over the next few weeks as investors wait for the Supreme Court ruling and as more companies start reporting earnings.
Now, I'm really looking forward to the big tech earnings because the tech sector has been a weak spot so far this year, and we'll see if that bounces back if these big tech giants post strong earnings.
Oh, and don't forget, we also got the beef between President Trump and Fed Chair Jerome Powell.
Now, speaking of the Fed, our deep dive for tomorrow is going to be about the history of the Federal Reserve.
We're going to talk about why it was formed, some of the failures the Fed has had in the past, and why an independent Fed is so important.
So if you want to learn more about the Federal Reserve, keep an eye on your podcast feed for that.
Also, I have to mention, this is kind of crazy, but I was actually quoted in an article in the Wall Street Journal this week about Fed Chair Jerome Powell.
The reporter who wrote the article, Hannah Aaron Lang, she did a great job on the piece.
She asked me why I thought that Powell gets memes so much on the internet.
And I said, it's because he has aura.
Now, I said a bunch of other stuff, too, but they ran with the aura quote, which I think is just great.
We even got a mention on The Wall Street Journal's Instagram page as well.
So, yeah, that was a pretty surreal moment getting quoted in The Wall Street Journal.
We'll put a link to the article in the description if you guys want to check that out.
Let's run through some headlines, starting with Eli Lilly and Novo Nordisk.
Eli Lilly and Novo Nordisk are being sued over their GLP-1 duopoly.
This lawsuit was filed by a compounding pharmacy called Strive Specialties, which alleges the two pharma giants are illegally blocking consumers from getting low-cost versions of their weight loss drugs.